ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 2413739-88-3
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. Evifacotrep

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product Name4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl}pyridazin-3(2H)-one
SynonymsEvifacotrep
5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one
4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl}pyridazin-3(2H)-one

Synonyms

Evifacotrep
5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one
4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl}pyridazin-3(2H)-one
3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-
CAS2413739-88-3
EINECS
Chemical FormulaC18H12ClF4N5O2
Molecular Weight441.77
inchi
Package10 mM * 1 mL;1 mg;5 mg;10 mg;25 mg;50 mg
PriceEmail to quote
DescriptionsEvifacotrep

Evifacotrep

MedChemExpress (MCE)

HY-132813

2413739-88-3

99.55%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US

Descriptions

Evifacotrep

Evifacotrep

MedChemExpress (MCE)

HY-132813

2413739-88-3

99.55%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US
may vary elsewhere.

Evifacotrep, a short transient receptor potential channel 5 and 4 (TRPC5/TRPC4) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases. Evifacotrep targets to TRPC5/TRPC4 with IC50s ≤50 nM.

Evifacotrep (1 μM
24 h) inhibits cell growth in ICLN-1694 cells(HEK-TRExhTRPC4)[1].

Evifacotrep (30 mg/kg
sc
once daily or twice daily for 10 days) results in reduced urinary albumin excretion on following injury with puromycinaminonucleoside (PAN)[1].

TRPC5[1] In Vitro Evifacotrep (1 μM
24 h) inhibits cell growth in ICLN-1694 cells(HEK-TRExhTRPC4)[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Evifacotrep Related Antibodies

| | | |

| | | | | |



[1]. WO2020061162

Supplier Websitehttps://www.medchemexpress.com/evifacotrep.html
Last Update2025-04-01 14:45:47
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-04-01 14:45:47

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-04-01 14:45:47

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-04-01 14:45:47

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-04-01 14:45:47

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-04-01 14:45:47

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-04-01 14:45:47

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-04-01 14:45:47

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-04-01 14:45:47
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002